FEB 05 2018, NEW PATENTS

FEB 052018

12 new patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	WO-2018023009	LURASIDONE	CONCERT	Bipolar I disorder; Schizophrenia
2	WO-2018022704	SELEXIPAG	TEVA	Pulmonary artery hypertension
3	WO-2018021818	FEBUXOSTAT	HANMI	Gout; Hyperuricemia; Tumor lysis syndrome
4	WO-2018021517	AMISELIMOD	MITSUBISHI	Autoimmune disease; Crohns disease; Inflammatory bowel disease; Multiple sclerosis; Psoriasis
5	WO-2018020506	CANAGLIFLOZIN	NATCO	Non-insulin dependent diabetes
6	WO-2018020450	ELUXADOLINE	LUPIN	Diarrhea predominant irritable bowel syndrome
7	WO-2018020406	BELINOSTAT	FRASENIUS	CANCER
8	WO-2018020380	DOLUTEGRAVIR	LUPIN	HIV infection
9	WO-2018020366	TRANYLCYPROMINE	GSK	Depression; Parkinsons disease
10	WO-2018019549	OMACETAXINE	INDENA	Chronic myelocytic leukemia
11	WO-2018019196	IXAZOMIB	SHENZEN	CANCER
12	WO-2018018986	CERITINIB	ARROMAX	Cardiovascular disease; Infectious disease; Inflammatory disease; Metabolic disorder; Viral infection
13
14
15
16